• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GAP
Click for more information
0.00% 12.0¢

GALE PACIFIC LIMITED - Charts / Financials

Market Cap $34.08M  ! watchlist Created with Sketch. Add to my watchlist
Consumer Cyclical

GALE Pacific Limited is an Australia-based manufacturer of technical fabrics used for... GALE Pacific Limited is an Australia-based manufacturer of technical fabrics used for consumer and commercial applications around the world. The Company's segments include Americas (AMR), Australia/New Zealand (ANZ) and Developing Markets (DEV). The Company's retail brands include Coolaroo and Zone Interiors. Its commercial brand is GALE Pacific Commercial. The Company's consumer products, marketed under the Coolaroo brand, include outdoor roller shades, shade sails, shade and garden fabrics, shade structures and pet products. The Company's commercial products, marketed under the GALE Pacific Commercial brand, include knitted, coated, and advanced polymer fabrics used in a number of applications across the agricultural, horticultural, aquacultural, architectural, construction, mining, and packaging industries. Zone Interiors' do-it-yourself (DIY) window furnishings include a range of easy-to-install venetian and roller blinds in a range of standard sizes and modern colors.More

refresh Created with Sketch. REFRESH
Last update - 11.00am 02/10/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
1 12.5¢ 61   1 13.0¢ 18032

Directors & Senior Management

Mr. Troy Mortleman Group Chief Executive Officer, Director
Mr. Arjun Bagawandas Interim Chief Financial Officer
Ms. Sheryl Smith Chief Financial Officer
Mr. Matt Russell Chief Human Resource Officer
Mr. Kevin Harshaw Vice President, General Manager of the Americas
Mr. Nathan Birckhead Global Vice President - Information Technology
Mr. Adam Boccelli Global Vice President - Supply Chain
Ms. Sophie Karzis Company Secretary
Mr. David J. Allman Non-Executive Independent Chairman of the Board
Mr. Peter Landos Non-Executive Director
Ms. Donna McMaster Non-Executive Director
Mr. Thomas Stianos Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
12.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $34.08M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 61 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
13.0¢ 18032 1
View Market Depth
Last trade - 11.00am 02/10/2024 (20 minute delay) ?

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
PainChek close to finding out if FDA approves its flagship app for use in dementia care PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.